OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases
Andrea Duminuco, Elena Torre, Giuseppe A. Palumbo, et al.
Current Hematologic Malignancy Reports (2023) Vol. 18, Iss. 5, pp. 176-189
Closed Access | Times Cited: 14
Andrea Duminuco, Elena Torre, Giuseppe A. Palumbo, et al.
Current Hematologic Malignancy Reports (2023) Vol. 18, Iss. 5, pp. 176-189
Closed Access | Times Cited: 14
Showing 14 citing articles:
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis
Mariarita Spampinato, Cesarina Giallongo, Sebastiano Giallongo, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Mariarita Spampinato, Cesarina Giallongo, Sebastiano Giallongo, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience
Andrea Duminuco, Anna Bulla, Rosamaria Rosso, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 111-111
Open Access
Andrea Duminuco, Anna Bulla, Rosamaria Rosso, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 111-111
Open Access
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis
Andrea Duminuco, Helen T. Chifotides, Sebastiano Giallongo, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 154-154
Open Access | Times Cited: 12
Andrea Duminuco, Helen T. Chifotides, Sebastiano Giallongo, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 154-154
Open Access | Times Cited: 12
Treatment of Myeloproliferative Neoplasms With Janus Kinase Inhibitors: A Meta‐Analysis of Cardiovascular Safety
Roberta Dunn, Edouard Long, L. Gagnon, et al.
eJHaem (2025) Vol. 6, Iss. 1
Open Access
Roberta Dunn, Edouard Long, L. Gagnon, et al.
eJHaem (2025) Vol. 6, Iss. 1
Open Access
Development of a natural language processing pipeline for assessment of cardiovascular risk in myeloproliferative neoplasms
Andrea Duminuco, Joshua Au Yeung, Raj Vaghela, et al.
HemaSphere (2024) Vol. 8, Iss. 8
Open Access | Times Cited: 3
Andrea Duminuco, Joshua Au Yeung, Raj Vaghela, et al.
HemaSphere (2024) Vol. 8, Iss. 8
Open Access | Times Cited: 3
Emergencies in Hematology: Why, When and How I Treat?
Andrea Duminuco, Vittorio Del Fabro, Luca Patanè, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7572-7572
Open Access | Times Cited: 3
Andrea Duminuco, Vittorio Del Fabro, Luca Patanè, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7572-7572
Open Access | Times Cited: 3
Polycythemia Vera: Barriers to and Strategies for Optimal Management
Andrea Duminuco, Patrick Harrington, Claire Harrison, et al.
Blood and Lymphatic Cancer Targets and Therapy (2023) Vol. Volume 13, pp. 77-90
Open Access | Times Cited: 8
Andrea Duminuco, Patrick Harrington, Claire Harrison, et al.
Blood and Lymphatic Cancer Targets and Therapy (2023) Vol. Volume 13, pp. 77-90
Open Access | Times Cited: 8
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients
Renata Mangione, Cesarina Giallongo, Andrea Duminuco, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 490-490
Open Access | Times Cited: 2
Renata Mangione, Cesarina Giallongo, Andrea Duminuco, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 490-490
Open Access | Times Cited: 2
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease
Lucia Gozzo, Salvatore Leotta, Giovanni Luca Romano, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4273-4273
Open Access | Times Cited: 1
Lucia Gozzo, Salvatore Leotta, Giovanni Luca Romano, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4273-4273
Open Access | Times Cited: 1
Andrea Duminuco, Adrián Mosquera Orgueira, Antonella Nardo, et al.
Cancer Reports (2023) Vol. 6, Iss. 10
Open Access | Times Cited: 4
Myelofibrosis: In Search for BETter Targeted Therapies
Giuseppe A. Palumbo, Andrea Duminuco
Journal of Clinical Oncology (2023) Vol. 41, Iss. 32, pp. 5044-5048
Closed Access | Times Cited: 2
Giuseppe A. Palumbo, Andrea Duminuco
Journal of Clinical Oncology (2023) Vol. 41, Iss. 32, pp. 5044-5048
Closed Access | Times Cited: 2
Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point?
Andrea Duminuco, Antonella Nardo, Giuseppe A. Palumbo
Hematological Oncology (2024) Vol. 42, Iss. 2
Closed Access
Andrea Duminuco, Antonella Nardo, Giuseppe A. Palumbo
Hematological Oncology (2024) Vol. 42, Iss. 2
Closed Access
Potential application of bulk RNA sequence in MPNs clinic routine
Shenglong Li, Sanyun Wu, Mingli Xu, et al.
Research Square (Research Square) (2024)
Open Access
Shenglong Li, Sanyun Wu, Mingli Xu, et al.
Research Square (Research Square) (2024)
Open Access
Applications of artificial intelligence to myeloproliferative neoplasms: a narrative review
Andrew Srisuwananukorn, Jordan E. Krull, Qin Ma, et al.
Expert Review of Hematology (2024) Vol. 17, Iss. 10, pp. 669-677
Open Access
Andrew Srisuwananukorn, Jordan E. Krull, Qin Ma, et al.
Expert Review of Hematology (2024) Vol. 17, Iss. 10, pp. 669-677
Open Access
